Muzinich & Company Lowered Its Pennantpark Investment C (PNNT) Holding by $2.93 Million; Thompson Rubinstein Investment Management Raised Holding in Novartis Ag Spon Adr (NVS)

April 17, 2018 - By Marguerite Chambers

Novartis AG (NYSE:NVS) Logo

Thompson Rubinstein Investment Management Inc increased its stake in Novartis Ag Spon Adr (NVS) by 8.39% based on its latest 2017Q4 regulatory filing with the SEC. Thompson Rubinstein Investment Management Inc bought 5,795 shares as the company’s stock declined 4.22% with the market. The institutional investor held 74,866 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $6.29 million, up from 69,071 at the end of the previous reported quarter. Thompson Rubinstein Investment Management Inc who had been investing in Novartis Ag Spon Adr for a number of months, seems to be bullish on the $191.62 billion market cap company. The stock increased 0.57% or $0.47 during the last trading session, reaching $81.64. About 2.42 million shares traded or 39.70% up from the average. Novartis AG (NYSE:NVS) has risen 5.79% since April 17, 2017 and is uptrending. It has underperformed by 5.76% the S&P500.

Muzinich & Company decreased its stake in Pennantpark Investment C (PNNT) by 21.38% based on its latest 2017Q4 regulatory filing with the SEC. Muzinich & Company sold 488,343 shares as the company’s stock declined 3.30% with the market. The institutional investor held 1.80M shares of the company at the end of 2017Q4, valued at $12.41M, down from 2.28 million at the end of the previous reported quarter. Muzinich & Company who had been investing in Pennantpark Investment C for a number of months, seems to be less bullish one the $497.43 million market cap company. The stock increased 1.45% or $0.1 during the last trading session, reaching $7. About 261,139 shares traded. PennantPark Investment Corporation (NASDAQ:PNNT) has declined 13.46% since April 17, 2017 and is downtrending. It has underperformed by 25.01% the S&P500.

Thompson Rubinstein Investment Management Inc, which manages about $259.90 million and $303.75 million US Long portfolio, decreased its stake in Bruker Corporation (NASDAQ:BRKR) by 28,185 shares to 134,447 shares, valued at $4.61M in 2017Q4, according to the filing.

Among 16 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 4 Sell and 7 Hold. Therefore 31% are positive. Novartis Ag had 36 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Novartis AG (NYSE:NVS) earned “Market Perform” rating by Leerink Swann on Thursday, January 25. The rating was maintained by J P Morgan Chase Co with “Neutral” on Friday, June 16. The stock has “Hold” rating by Barclays Capital on Friday, June 23. Cowen & Co maintained Novartis AG (NYSE:NVS) on Friday, October 13 with “Hold” rating. The stock of Novartis AG (NYSE:NVS) has “Underperform” rating given on Wednesday, October 28 by Mainfirst. Cowen & Co maintained the shares of NVS in report on Friday, February 2 with “Hold” rating. The rating was downgraded by UBS to “Neutral” on Friday, April 1. The firm earned “Underperform” rating on Wednesday, July 5 by Credit Suisse. The firm has “Neutral” rating given on Friday, March 24 by JP Morgan. The stock of Novartis AG (NYSE:NVS) earned “Hold” rating by Cowen & Co on Wednesday, August 9.

Among 12 analysts covering Pennant Investment (NASDAQ:PNNT), 5 have Buy rating, 0 Sell and 7 Hold. Therefore 42% are positive. Pennant Investment had 34 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of PennantPark Investment Corporation (NASDAQ:PNNT) has “Neutral” rating given on Monday, July 18 by JP Morgan. The stock has “Hold” rating by Keefe Bruyette & Woods on Monday, September 25. The stock has “Buy” rating by Ladenburg Thalmann on Friday, February 9. The company was maintained on Wednesday, August 10 by JMP Securities. On Friday, January 19 the stock rating was maintained by Jefferies with “Hold”. The firm has “Market Perform” rating given on Thursday, May 11 by JMP Securities. The firm has “Neutral” rating by Ladenburg Thalmann given on Thursday, February 9. The firm earned “Buy” rating on Tuesday, November 22 by Ladenburg Thalmann. The firm has “Mkt Perform” rating by FBR Capital given on Wednesday, November 23. Jefferies maintained PennantPark Investment Corporation (NASDAQ:PNNT) rating on Friday, November 3. Jefferies has “Hold” rating and $8.0 target.

PennantPark Investment Corporation (NASDAQ:PNNT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.